Publication | Closed Access

Study of kaempferol in the treatment of rheumatoid arthritis through modulation of the NLRP3/CASP1/GSDMD axis and T-cell activation: Based on network pharmacology, single-cell analysis, and experimental validation

InflammationRheumatologyNetwork PharmacologyAnti-inflammatoryRheumatoid DisorderAutoimmune DiseaseMedicineImmunologyChronic InflammationAutoimmunityInflammatory Rheumatic DiseasePharmacotherapyPharmacologyNlrp3/casp1/gsdmd AxisRheumatoid Arthritis